Wird geladen...

Clinical Valve Thrombosis and Subclinical Leaflet Thrombosis Following Transcatheter Aortic Valve Replacement: Is There a Need for a Patient-Tailored Antithrombotic Therapy?

Transcatheter aortic valve replacement (TAVR) has become an established therapeutic option for patients with symptomatic, severe aortic valve stenosis at increased surgical risk. Antithrombotic therapy after TAVR aims to prevent transcatheter heart valve (THV) thrombosis, in which two different enti...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Front Cardiovasc Med
Hauptverfasser: Rosseel, Liesbeth, De Backer, Ole, Søndergaard, Lars
Format: Artigo
Sprache:Inglês
Veröffentlicht: Frontiers Media S.A. 2019
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6482296/
https://ncbi.nlm.nih.gov/pubmed/31058168
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcvm.2019.00044
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!